Difficult times have knocked at our doors, but we will survive this and we will defeat SARS-CoV2 because we have the resources. However, the more people will involve in the current situation, the quicker we will be able to respond and react. Babu™ has officially announced opening its scientific resources to any research facility that would require our manpower, expertise, and marketing tools. Even though our scientific resources in the fields of immunology and microbiology are limited, we will give whatever we can give and we will share whatever we can share. We are kindly asking others to follow the footsteps of all biotech, IT, PR, marketing, healthcare, and other companies that already have done it as well. Let's get through it TOGETHER!
With sincere wishes of health,
We are extremely proud that AGT and our Institute have come closer to establishing a tight and immensely powerful partnership for the next several years! Where creativty cures, people will live longer, healthier, and better. This is the promise that both companies make.
Watch a video recorded by AGT speaking of the company's fine biotech advancements and how their progress meets the Mission and Vision of Babu™.
Babu™ is proud to announce its first promotional video, where the Institute's founder and CEO, Steve Liebich, and the CFO, Patrick Hurley, present the main ideas that build Babu™ and explain why it is destined for grandeur. Transparency and vivid dialogue with other people is what makes things turn around - Babu™ wants to talk about the future, but most importantly - Babu™ wants to become the future!
Babu™ is proud to officially announce its investment and ongoing partnership with the American Gene Technologies (AGT) – one of the world’s finest gene therapy biotechnology companies. Using a “proprietary gene delivery platform to rapidly develop patented gene and cell therapies”, AGT has created a working platform of genetic tools and components to cure HIV, phenylketonuria (PKU), and liver cancer. With their revolutionary gene therapy platform, the potential to save millions of lives from once incurable diseases becomes unlocked. This is the future of our decade that Babu™ brings to your home. Together we will bring you longer, healthier, and better lives!
To learn more on how Babu™ and AGT envision their future together you shall read this statement of future partnership.
Telocyte’s founder and president, Michael Fossel, has recently published a highly influential paper in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association which was called by the editors as “the most important article we have ever published.” The paper already has had more than 300 requests for reprints. This article not only explains why telomere- based theories of ageing are the future in modern biogerontology, but also delivers the most up- to-date characterization of pathophysiology of Alzheimer’s disease (AD). Telocyte’s gene therapy developed for AD, and supported by Babu™, can be better understood with the rationale within Dr. Fossel’s article that can be found here.
Christmas is the time in our rushing world when dreams come true, hearts beat faster, joy shines brighter, and happiness finds its way into our homes. As Charles Dickens wrote, ‘I will honour Christmas in my heart, and try to keep it all the year,’ so do we wish you all this truly special gift of everlasting dreams, excitement, joy, and happiness. We promise you that Babu™ will never change either and will always be there with you and for you. Please accept our heartfelt Christmas and New Year wishes and may we all live longer, healthier, and better!
We at Babu™ are always looking for scientific projects to invest in and soon we will open the Submission Page for every research group interested in partnering with Babu™. The Institute is now preparing for the next round of investments for year 2020 and we are excited to support new scientific projects that have the potential to change the world for the better. Babu™ funds only the most competitive research studies and new technological advancements. If your research falls into Babu’s™ Three Pillars (biogerontology, developmental biology, and regenerative medicine & stem cells), addresses a ground-breaking and revolutionary study, and meets other criteria – PREPARE your submission now!
We take our Mission and Vision very seriously and our main task is to accelerate three generations of scientific work in one decade. If you qualify, you can expect to receive an investment of as little as 50% of your expenditures covered by Babu™. So if you think your project is the next big development in one of Babu’s Three Pillars, PREPARE your submission.
Babu™ is currently involved in finding the proper candidates for the open Scientific Advisory Board (SAB) seats and would like to offer this opportunity to everybody who is interested in making the world a better place. If your skills and experience fall into one or more of Babu’s™ Three Pillars (biogerontology, developmental biology, and regenerative medicine & stem cells) and you are highly accomplished in the field of your interest, contact us! You can find more information on Babu’s™ SAB through our website. Together we will make people live longer, healthier and better!
We develop and progress with every new day. If you want to keep up with these changes, please check out our website. We promise to deliver only the highest quality of research and provide all the needed information so you can participate in the quest of Babu™. Thank you for supporting us in every possible manner!